Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Nordsjællands TandlægeCenter I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.1%   Bankruptcy risk   2.3% 2.5% 2.2% 1.7% 4.9% 4.4% 18.4% 12.4%   Credit score (0-100)   66 64 67 73 43 47 1 1   Credit rating   BBB BBB BBB A BBB BBB B BB   Credit limit (kDKK)   0.1 0.0 0.3 12.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   11,500 13,609 14,468 15,093 16,440 17,426 0.0 0.0   EBITDA   3,312 4,763 5,166 5,417 6,364 6,185 0.0 0.0   EBIT   3,312 4,763 5,166 5,417 6,364 6,185 0.0 0.0   Pre-tax profit (PTP)   3,430.3 4,903.0 5,299.7 5,537.8 6,345.7 6,180.3 0.0 0.0   Net earnings   3,430.3 4,903.0 5,299.7 5,537.8 6,345.7 6,180.3 0.0 0.0   Pre-tax profit without non-rec. items   3,430 4,903 5,300 5,538 6,346 6,180 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   4,752 4,691 4,312 3,858 647 954 0.0 0.0   Interest-bearing liabilities   0.0 1.0 0.0 28.0 0.3 0.8 0.0 0.0   Balance sheet total (assets)   6,148 6,229 5,951 6,747 2,891 2,808 0.0 0.0   Net Debt   -511 -914 -945 -1,244 -968 -1,190 0.0 0.0     See the entire balance sheet 1000.0 Volume  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   11,500 13,609 14,468 15,093 16,440 17,426 0.0 0.0   Gross profit growth   0.0% 18.3% 6.3% 4.3% 8.9% 6.0% -100.0% 0.0%   Employees   0 0 16 17 17 18 0 0   Employee growth %   0.0% 0.0% 0.0% 6.3% 0.0% 5.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   6,148 6,229 5,951 6,747 2,891 2,808 0 0   Balance sheet change%   0.0% 1.3% -4.5% 13.4% -57.2% -2.9% -100.0% 0.0%   Added value   3,312.4 4,762.5 5,166.1 5,417.0 6,364.3 6,185.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 -809 1,147 133 -471   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   28.8% 35.0% 35.7% 35.9% 38.7% 35.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   55.8% 79.2% 87.0% 87.2% 132.1% 217.3% 0.0% 0.0%   ROI %   72.2% 103.8% 117.0% 124.6% 246.4% 772.7% 0.0% 0.0%   ROE %   72.2% 103.9% 117.7% 135.6% 281.7% 771.9% 0.0% 0.0%   1000.0 Solidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Equity ratio %   80.4% 78.3% 78.4% 59.7% 24.7% 40.7% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -15.4% -19.2% -18.3% -23.0% -15.2% -19.2% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.7% 0.0% 0.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.4% 0.8% 3.6% 131.5% 1,974.1% 0.0% 0.0%   1000.0 Liquidity  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Quick Ratio   5.2 4.7 5.2 3.4 1.4 1.9 0.0 0.0   Current Ratio   4.4 4.0 3.7 3.0 1.3 1.5 0.0 0.0   Cash and cash equivalent   510.6 914.6 945.0 1,272.5 968.7 1,190.3 0.0 0.0   1000.0 Capital use efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   4,716.3 4,652.7 4,331.1 4,447.5 585.5 889.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 323 319 374 344 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 323 319 374 344 0 0   EBIT / employee   0 0 323 319 374 344 0 0   Net earnings / employee   0 0 331 326 373 343 0 0